Author/Editor     Matos, Aleš; Žargi, Miha
Title     Vpliv spremljajočih bolezni na uspeh zdravljenja bolnikov z rakom ustne votline
Translated title     Impact of comorbidity on treatment success of patients with oral cavity carcinoma
Type     članek
Source     Med Razgl
Vol. and No.     Letnik 43, št. Suppl 3
Publication year     2004
Volume     str. 309-12
Language     slo
Abstract     Studies performed in recent years have shown, comorbidity has an impact on treatment outcome and survival of patients with head and neck carcinoma. Cardiovascular, pulmonary and neurologic diseases are known to have the most unfavorable influence. We studied the influence of comorbidity on 5-year survival of patients with oral cavity carcinoma that were surgically treated on Clinic for Otorinolaryngology and Cervicofacial surgery in Ljubljana in the period from 1.1.1994 to 1.1.1999. In contrast to some other studies, our study did not confirm statistically significant correlation between 5-year survival and number of accompanied diseases. There was no statistically significant correlation between 5-year survival and hematocrit rate or ASA index as well.
Summary     Raziskave, opravljene v zadnjih letih, kažejo, da spremljajoče bolezni pomembno vplivajo na izid zdravljenja in preživetje bolnikov z rakom glave in vratu. Dokazano najbolj neugodno vplivajo bolezni srca in ožilja, bolezni pljuč ter nevrološke bolezni. V raziskavi smo proučili vpliv navedenih spremljajočih bolezni na 5-letno preživetje bolnikov z rakom ustne votline, ki so bili kirurško zdravljeni na Kliniki za ORL- in CF-kirurgijo v Ljubljani v obdobju od 1.1.1994 do 1.1.1999. V nasprotju z nekaterimi drugimi raziskavami naša raziskava ni potrdila statistično pomembne povezanosti med 5-letnim preživetjem in številom spremljajočih obolenj. Prav tako ni potrdila statistično pomembne povezanosti med 5-letnim preživetjem in predoperacijsko vrednostjo hematokrita ali ASA-indeksom.
Descriptors     MOUTH NEOPLASMS
COMORBIDITY
SURVIVAL ANALYSIS
NEOPLASM STAGING
CARCINOMA, SQUAMOUS CELL
HEMATOCRIT
RISK ASSESSMENT
INTRAOPERATIVE COMPLICATIONS
POSTOPERATIVE COMPLICATIONS